Cargando…
Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study
While it is known that accurate evaluation of overall survival (OS) and disease-specific survival (DSS) for patients with primary adrenal lymphoma (PAL) can affect their prognosis, no stable and effective prediction model exists. This study aimed to develop prediction models to evaluate survival. Th...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475110/ https://www.ncbi.nlm.nih.gov/pubmed/37660207 http://dx.doi.org/10.1038/s41598-023-41839-2 |
_version_ | 1785100649691611136 |
---|---|
author | Sun, Shiwei Wang, Yue Yao, Wei Yue, Peng Guo, Fuyu Deng, Xiaoqian Zhang, Jiandong Zhang, Yangang |
author_facet | Sun, Shiwei Wang, Yue Yao, Wei Yue, Peng Guo, Fuyu Deng, Xiaoqian Zhang, Jiandong Zhang, Yangang |
author_sort | Sun, Shiwei |
collection | PubMed |
description | While it is known that accurate evaluation of overall survival (OS) and disease-specific survival (DSS) for patients with primary adrenal lymphoma (PAL) can affect their prognosis, no stable and effective prediction model exists. This study aimed to develop prediction models to evaluate survival. This study enrolled 5448 patients with adrenal masses from the SEER Program. The influencing factors were selected using the least absolute shrinkage and selection operator regression model (LASSO) and Fine and Gray model (FGM). In addition, nomograms were constructed. Receiver operating characteristic curves and bootstrap self-sampling methods were used to verify the discrimination and consistency of the nomograms. The independent influencing factors for PAL survival were selected by LASSO and FGM, and three models were built: the OS, DSS, and FGS (DSS analysis by FGM) model. The areas under the curve and decision curve analyses indicated that the models were valid. This study developed survival prediction models to predict OS and DSS of patients with PAL. The FGS model was more accurate than the DSS model in the short term. Above all, these models should offer benefits to patients with PAL in terms of the treatment modality choice and survival evaluation. |
format | Online Article Text |
id | pubmed-10475110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-104751102023-09-04 Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study Sun, Shiwei Wang, Yue Yao, Wei Yue, Peng Guo, Fuyu Deng, Xiaoqian Zhang, Jiandong Zhang, Yangang Sci Rep Article While it is known that accurate evaluation of overall survival (OS) and disease-specific survival (DSS) for patients with primary adrenal lymphoma (PAL) can affect their prognosis, no stable and effective prediction model exists. This study aimed to develop prediction models to evaluate survival. This study enrolled 5448 patients with adrenal masses from the SEER Program. The influencing factors were selected using the least absolute shrinkage and selection operator regression model (LASSO) and Fine and Gray model (FGM). In addition, nomograms were constructed. Receiver operating characteristic curves and bootstrap self-sampling methods were used to verify the discrimination and consistency of the nomograms. The independent influencing factors for PAL survival were selected by LASSO and FGM, and three models were built: the OS, DSS, and FGS (DSS analysis by FGM) model. The areas under the curve and decision curve analyses indicated that the models were valid. This study developed survival prediction models to predict OS and DSS of patients with PAL. The FGS model was more accurate than the DSS model in the short term. Above all, these models should offer benefits to patients with PAL in terms of the treatment modality choice and survival evaluation. Nature Publishing Group UK 2023-09-02 /pmc/articles/PMC10475110/ /pubmed/37660207 http://dx.doi.org/10.1038/s41598-023-41839-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Sun, Shiwei Wang, Yue Yao, Wei Yue, Peng Guo, Fuyu Deng, Xiaoqian Zhang, Jiandong Zhang, Yangang Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study |
title | Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study |
title_full | Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study |
title_fullStr | Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study |
title_full_unstemmed | Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study |
title_short | Development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study |
title_sort | development and validation of nomograms to predict survival of primary adrenal lymphoma: a population-based retrospective study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475110/ https://www.ncbi.nlm.nih.gov/pubmed/37660207 http://dx.doi.org/10.1038/s41598-023-41839-2 |
work_keys_str_mv | AT sunshiwei developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy AT wangyue developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy AT yaowei developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy AT yuepeng developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy AT guofuyu developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy AT dengxiaoqian developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy AT zhangjiandong developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy AT zhangyangang developmentandvalidationofnomogramstopredictsurvivalofprimaryadrenallymphomaapopulationbasedretrospectivestudy |